|
METTL8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.568000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.402100E-02 |
| Normal-vs-Stage2 |
3.088200E-01 |
| Normal-vs-Stage3 |
2.352400E-02 |
| Normal-vs-Stage4 |
8.750600E-01 |
| Stage1-vs-Stage2 |
9.005200E-01 |
| Stage1-vs-Stage3 |
3.391200E-01 |
| Stage1-vs-Stage4 |
5.691400E-01 |
| Stage2-vs-Stage3 |
4.644000E-01 |
| Stage2-vs-Stage4 |
6.571600E-01 |
| Stage3-vs-Stage4 |
3.326400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.909900E-02 |
| Normal-vs-AfricanAmerican |
8.436900E-03 |
| Normal-vs-Asian |
3.885400E-01 |
| Caucasian-vs-AfricanAmerican |
1.029050E-01 |
| Caucasian-vs-Asian |
2.824400E-01 |
| AfricanAmerican-vs-Asian |
1.825000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.162100E-03 |
| Normal-vs-Female |
8.767200E-01 |
| Male-vs-Female |
5.496500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.508800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.342000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.818200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.279380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.986000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.813400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.412200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.487200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.241400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.121800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.350400E-02 |
| Normal-vs-Grade 2 |
1.277600E-01 |
| Normal-vs-Grade 3 |
2.306200E-01 |
| Normal-vs-Grade 4 |
1.595360E-01 |
| Grade 1-vs-Grade 2 |
1.559960E-01 |
| Grade 1-vs-Grade 3 |
1.829550E-01 |
| Grade 1-vs-Grade 4 |
2.716600E-01 |
| Grade 2-vs-Grade 3 |
9.654400E-01 |
| Grade 2-vs-Grade 4 |
8.238400E-01 |
| Grade 3-vs-Grade 4 |
8.093200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.694810E-01 |
| Normal-vs-ccB subtype |
1.487960E-01 |
| ccA subtype-vs-ccB subtype |
7.234000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.043800E-02 |
| Normal-vs-N1 |
4.791600E-01 |
| N0-vs-N1 |
1.847200E-01 |
|
|
